12 Einträge gefunden

1. Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry

   1. Witzel, Isabell
   2. Müller, Volkmar
   3. Abenhardt, Wolfgang
   4. Kaufmann, Manfred
   5. Schoenegg, Winfried
   6. Schneeweis, Andreas
   7. Jänicke, Fritz

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
2. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.

   1. von Minckwitz, Gunter
   2. Untch, Michael
   3. Nüesch, Eveline
   4. Loibl, Sibylle
   5. Kaufmann, Manfred
   6. Kümmel, Sherko
   7. Fasching, Peter A

   2011 - Forschungsinformationssystem des UKE
3. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.

   1. Sänger, Nicole
   2. Harms-Effenberger, Katharina
   3. Riethdorf, Sabine
   4. Viviane, Van Haasteren
   5. Gauwerky, Johannes
   6. Wiegratz, Inka
   7. Strebhardt, Klaus

   2011 - Forschungsinformationssystem des UKE
4. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

   1. Karn, Thomas
   2. Ruckhäberle, Eugen
   3. Hanker, Lars
   4. Müller, Volkmar
   5. Schmidt, Marcus
   6. Solbach, Christine
   7. Gätje, Regine

   2011 - Forschungsinformationssystem des UKE
5. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.

   1. Rody, Achim
   2. Karn, Thomas
   3. Ruckhäberle, Eugen
   4. Hanker, Lars
   5. Metzler, Dirk
   6. Müller, Volkmar
   7. Solbach, Christine

   2009 - Forschungsinformationssystem des UKE
6. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

   1. Kaufmann, Manfred
   2. Hortobagyi, Gabriel N
   3. Goldhirsch, Aron
   4. Scholl, Suzy
   5. Makris, Andreas
   6. Valagussa, Pinuccia
   7. Blohmer, Jens-Uwe

   2006 - Forschungsinformationssystem des UKE
7. Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy.

   1. Solbach, Christine
   2. Roller, Marc
   3. Nicolettri, Maria
   4. Budischewski, Kai
   5. Knecht, Rainald
   6. Kaufmann, Manfred

   2005 - Forschungsinformationssystem des UKE
8. Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.

   1. Solbach, Christine
   2. Roller, Marc
   3. Peters, Silke
   4. Nicoletti, Maria
   5. Kaufmann, Manfred
   6. Knecht, Rainald

   2005 - Forschungsinformationssystem des UKE
9. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

   1. Spänkuch, Birgit
   2. Matthess, Yves
   3. Knecht, Rainald
   4. Zimmer, Brigitte
   5. Kaufmann, Manfred
   6. Strebhardt, Klaus

   2004 - Forschungsinformationssystem des UKE
10. Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.

    1. Solbach, Christine
    2. Roller, Marc
    3. Ahr, Andre
    4. Loibl, Sibylle
    5. Nicoletti, Maria
    6. Stegmueller, Manfred
    7. Kreysch, Hans-Georg

    2002 - Forschungsinformationssystem des UKE
11. Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

    1. Solbach, Christine
    2. Sterner-Kock, Anja
    3. Roller, Marc
    4. Schnürch, Hans Georg
    5. Stegmüller, Manfred
    6. Caspar-Bell, Gudrun
    7. Schumm-Draeger, Petra Maria

    2002 - Forschungsinformationssystem des UKE - frei zugänglich
12. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

    1. Spänkuch-Schmitt, Birgit
    2. Wolf, Georg
    3. Solbach, Christine
    4. Loibl, Sibylle
    5. Knecht, Rainald
    6. Stegmüller, Manfred
    7. von Minckwitz, Gunter

    2002 - Forschungsinformationssystem des UKE